Kyverna Therapeutics Inc (KYTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Operating Expenses | 33,435 | 29,358 | 21,377 | 16,282 | 13,302 |
| Operating Income | -33,435 | -29,358 | -21,377 | -16,282 | -13,302 |
| Interest Expense | 39 | 44 | 47 | 50 | 46 |
| Other Income | 4,671 | 2,709 | 757 | 867 | 257 |
| Pre-tax Income | -28,803 | -26,693 | -20,667 | -15,465 | -13,091 |
| Net Income Continuous | -28,803 | -26,693 | -20,667 | -15,465 | -13,091 |
| Net Income | $-28,803 | $-26,693 | $-20,667 | $-15,465 | $-13,091 |
| EPS Basic Total Ops | -0.67 | -1.12 | -33.38 | -23.27 | -20.86 |
| EPS Basic Continuous Ops | -0.67 | -1.12 | -33.36 | -23.26 | -20.85 |
| EPS Diluted Total Ops | -0.67 | -1.12 | -33.38 | -23.27 | -20.86 |
| EPS Diluted Continuous Ops | -0.67 | -1.12 | -33.36 | -23.26 | -20.85 |
| EPS Diluted Before Non-Recurring Items | -0.67 | -1.12 | N/A | N/A | N/A |
| EBITDA(a) | $-32,905 | $-28,876 | $-20,915 | $-15,844 | $-12,889 |